IL-2 can signal via chemokine receptors to promote regulatory T cells’ suppressive function
Canonical interleukin-2 (IL-2) signaling via the high-affinity CD25-containing IL-2 receptor-Janus kinase (JAK)1,3-signal transducer and activator of transcription 5 (STAT5) pathway is essential for development and maintenance of CD4+CD25HiFoxp3+ regulatory T cells (Tregs) that support immune homeos...
Saved in:
Published in | Cell reports (Cambridge) Vol. 42; no. 8; p. 112996 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
29.08.2023
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Canonical interleukin-2 (IL-2) signaling via the high-affinity CD25-containing IL-2 receptor-Janus kinase (JAK)1,3-signal transducer and activator of transcription 5 (STAT5) pathway is essential for development and maintenance of CD4+CD25HiFoxp3+ regulatory T cells (Tregs) that support immune homeostasis. Here, we report that IL-2 signaling via an alternative CD25-chemokine receptor pathway promotes the suppressive function of Tregs. Using an antibody against CD25 that biases IL-2 signaling toward this alternative pathway, we establish that this pathway increases the suppressive activity of Tregs and ameliorates murine experimental autoimmune encephalomyelitis (EAE). Furthermore, heparan sulfate, an IL-2-binding element of cell surfaces and extracellular matrix, or an engineered IL-2 immunocytokine can also direct IL-2 signaling toward this alternative pathway. Overall, these data reveal a non-canonical mechanism for IL-2 signaling that promotes suppressive functions of Tregs, further elucidates how IL-2 supports immune homeostasis, and suggests approaches to promote or suppress Treg functions.
[Display omitted]
•IL-2 can signal via chemokine receptors (CRs) in addition to the βγ IL-2 receptors•An anti-CD25 induces a CD25-IL-2-CCR7 complex and enforces CR signaling•This non-canonical IL-2 signaling pathway promotes Tregs’ suppressive function•A modified form of this anti-CD25 ameliorates experimental autoimmunity
IL-2 shapes the immune response. Sun et al. report that IL-2 signaling via a CD25-chemokine receptor pathway promotes increased regulatory T cells’ suppressive function. An anti-CD25 or heparan sulfate biases IL-2 signaling toward this chemokine receptor pathway, and administration of a modified form of this anti-CD25 ameliorates murine experimental autoimmune encephalomyelitis. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 AUTHOR CONTRIBUTIONS H.S. and M.H.G. conceived the study, designed experiments, analyzed data, and wrote the manuscript. H.L., H.S., M.A.L.-R., J.A., M.F.d.L., and F.L. designed and executed experiments, analyzed data, and wrote the manuscript. J.B.S. and D.V. provided critical reagents. A.R.G. and J.T.C. provided critical conceptual input. Q.D. and W.M. designed and performed experiments. H.S., H.L., M.A.L.-R., J.A., F.L., J.T.C., J.B.S., and M.H.G. edited the manuscript. |
ISSN: | 2211-1247 2211-1247 |
DOI: | 10.1016/j.celrep.2023.112996 |